Cargando…

Integrative Analysis of Intrahepatic Cholangiocarcinoma Subtypes for Improved Patient Stratification: Clinical, Pathological, and Radiological Considerations

SIMPLE SUMMARY: Liver cancer subtypes differ in prognosis and genetic alterations. An accurate diagnosis made on time is the key aspect of clinical decision-making. Hence, a correct diagnosis is of pivotal importance for individual patients. In this study, we identified the most relevant clinical, r...

Descripción completa

Detalles Bibliográficos
Autores principales: Gerber, Tiemo S., Müller, Lukas, Bartsch, Fabian, Gröger, Lisa-Katharina, Schindeldecker, Mario, Ridder, Dirk A., Goeppert, Benjamin, Möhler, Markus, Dueber, Christoph, Lang, Hauke, Roth, Wilfried, Kloeckner, Roman, Straub, Beate K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9264781/
https://www.ncbi.nlm.nih.gov/pubmed/35804931
http://dx.doi.org/10.3390/cancers14133156
_version_ 1784743038961057792
author Gerber, Tiemo S.
Müller, Lukas
Bartsch, Fabian
Gröger, Lisa-Katharina
Schindeldecker, Mario
Ridder, Dirk A.
Goeppert, Benjamin
Möhler, Markus
Dueber, Christoph
Lang, Hauke
Roth, Wilfried
Kloeckner, Roman
Straub, Beate K.
author_facet Gerber, Tiemo S.
Müller, Lukas
Bartsch, Fabian
Gröger, Lisa-Katharina
Schindeldecker, Mario
Ridder, Dirk A.
Goeppert, Benjamin
Möhler, Markus
Dueber, Christoph
Lang, Hauke
Roth, Wilfried
Kloeckner, Roman
Straub, Beate K.
author_sort Gerber, Tiemo S.
collection PubMed
description SIMPLE SUMMARY: Liver cancer subtypes differ in prognosis and genetic alterations. An accurate diagnosis made on time is the key aspect of clinical decision-making. Hence, a correct diagnosis is of pivotal importance for individual patients. In this study, we identified the most relevant clinical, radiological, and histological parameters for an improved subtype diagnosis of intrahepatic cholangiocarcinoma. As a result of our study, the radiologist should consider factors such as growth pattern, location, and contrast agent behavior. For the pathologist, precursor lesions, mucin secretion, and a periductal-infiltrating growth are of utmost importance, while immunohistochemical analyses are essential for exclusion of extrahepatic malignancies, but have so far only value for iCCA subtype analysis in the context with other parameters. ABSTRACT: Intrahepatic cholangiocarcinomas (iCCAs) may be subdivided into large and small duct types that differ in etiology, molecular alterations, therapy, and prognosis. Therefore, the optimal iCCA subtyping is crucial for the best possible patient outcome. In our study, we analyzed 148 small and 84 large duct iCCAs regarding their clinical, radiological, histological, and immunohistochemical features. Only 8% of small duct iCCAs, but 27% of large duct iCCAs, presented with initial jaundice. Ductal tumor growth pattern and biliary obstruction were significant radiological findings in 33% and 48% of large duct iCCAs, respectively. Biliary epithelial neoplasia and intraductal papillary neoplasms of the bile duct were detected exclusively in large duct type iCCAs. Other distinctive histological features were mucin formation and periductal-infiltrating growth pattern. Immunohistochemical staining against CK20, CA19-9, EMA, CD56, N-cadherin, and CRP could help distinguish between the subtypes. To summarize, correct subtyping of iCCA requires an interplay of several factors. While the diagnosis of a precursor lesion, evidence of mucin, or a periductal-infiltrating growth pattern indicates the diagnosis of a large duct type, in their absence, several other criteria of diagnosis need to be combined.
format Online
Article
Text
id pubmed-9264781
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-92647812022-07-09 Integrative Analysis of Intrahepatic Cholangiocarcinoma Subtypes for Improved Patient Stratification: Clinical, Pathological, and Radiological Considerations Gerber, Tiemo S. Müller, Lukas Bartsch, Fabian Gröger, Lisa-Katharina Schindeldecker, Mario Ridder, Dirk A. Goeppert, Benjamin Möhler, Markus Dueber, Christoph Lang, Hauke Roth, Wilfried Kloeckner, Roman Straub, Beate K. Cancers (Basel) Article SIMPLE SUMMARY: Liver cancer subtypes differ in prognosis and genetic alterations. An accurate diagnosis made on time is the key aspect of clinical decision-making. Hence, a correct diagnosis is of pivotal importance for individual patients. In this study, we identified the most relevant clinical, radiological, and histological parameters for an improved subtype diagnosis of intrahepatic cholangiocarcinoma. As a result of our study, the radiologist should consider factors such as growth pattern, location, and contrast agent behavior. For the pathologist, precursor lesions, mucin secretion, and a periductal-infiltrating growth are of utmost importance, while immunohistochemical analyses are essential for exclusion of extrahepatic malignancies, but have so far only value for iCCA subtype analysis in the context with other parameters. ABSTRACT: Intrahepatic cholangiocarcinomas (iCCAs) may be subdivided into large and small duct types that differ in etiology, molecular alterations, therapy, and prognosis. Therefore, the optimal iCCA subtyping is crucial for the best possible patient outcome. In our study, we analyzed 148 small and 84 large duct iCCAs regarding their clinical, radiological, histological, and immunohistochemical features. Only 8% of small duct iCCAs, but 27% of large duct iCCAs, presented with initial jaundice. Ductal tumor growth pattern and biliary obstruction were significant radiological findings in 33% and 48% of large duct iCCAs, respectively. Biliary epithelial neoplasia and intraductal papillary neoplasms of the bile duct were detected exclusively in large duct type iCCAs. Other distinctive histological features were mucin formation and periductal-infiltrating growth pattern. Immunohistochemical staining against CK20, CA19-9, EMA, CD56, N-cadherin, and CRP could help distinguish between the subtypes. To summarize, correct subtyping of iCCA requires an interplay of several factors. While the diagnosis of a precursor lesion, evidence of mucin, or a periductal-infiltrating growth pattern indicates the diagnosis of a large duct type, in their absence, several other criteria of diagnosis need to be combined. MDPI 2022-06-28 /pmc/articles/PMC9264781/ /pubmed/35804931 http://dx.doi.org/10.3390/cancers14133156 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Gerber, Tiemo S.
Müller, Lukas
Bartsch, Fabian
Gröger, Lisa-Katharina
Schindeldecker, Mario
Ridder, Dirk A.
Goeppert, Benjamin
Möhler, Markus
Dueber, Christoph
Lang, Hauke
Roth, Wilfried
Kloeckner, Roman
Straub, Beate K.
Integrative Analysis of Intrahepatic Cholangiocarcinoma Subtypes for Improved Patient Stratification: Clinical, Pathological, and Radiological Considerations
title Integrative Analysis of Intrahepatic Cholangiocarcinoma Subtypes for Improved Patient Stratification: Clinical, Pathological, and Radiological Considerations
title_full Integrative Analysis of Intrahepatic Cholangiocarcinoma Subtypes for Improved Patient Stratification: Clinical, Pathological, and Radiological Considerations
title_fullStr Integrative Analysis of Intrahepatic Cholangiocarcinoma Subtypes for Improved Patient Stratification: Clinical, Pathological, and Radiological Considerations
title_full_unstemmed Integrative Analysis of Intrahepatic Cholangiocarcinoma Subtypes for Improved Patient Stratification: Clinical, Pathological, and Radiological Considerations
title_short Integrative Analysis of Intrahepatic Cholangiocarcinoma Subtypes for Improved Patient Stratification: Clinical, Pathological, and Radiological Considerations
title_sort integrative analysis of intrahepatic cholangiocarcinoma subtypes for improved patient stratification: clinical, pathological, and radiological considerations
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9264781/
https://www.ncbi.nlm.nih.gov/pubmed/35804931
http://dx.doi.org/10.3390/cancers14133156
work_keys_str_mv AT gerbertiemos integrativeanalysisofintrahepaticcholangiocarcinomasubtypesforimprovedpatientstratificationclinicalpathologicalandradiologicalconsiderations
AT mullerlukas integrativeanalysisofintrahepaticcholangiocarcinomasubtypesforimprovedpatientstratificationclinicalpathologicalandradiologicalconsiderations
AT bartschfabian integrativeanalysisofintrahepaticcholangiocarcinomasubtypesforimprovedpatientstratificationclinicalpathologicalandradiologicalconsiderations
AT grogerlisakatharina integrativeanalysisofintrahepaticcholangiocarcinomasubtypesforimprovedpatientstratificationclinicalpathologicalandradiologicalconsiderations
AT schindeldeckermario integrativeanalysisofintrahepaticcholangiocarcinomasubtypesforimprovedpatientstratificationclinicalpathologicalandradiologicalconsiderations
AT ridderdirka integrativeanalysisofintrahepaticcholangiocarcinomasubtypesforimprovedpatientstratificationclinicalpathologicalandradiologicalconsiderations
AT goeppertbenjamin integrativeanalysisofintrahepaticcholangiocarcinomasubtypesforimprovedpatientstratificationclinicalpathologicalandradiologicalconsiderations
AT mohlermarkus integrativeanalysisofintrahepaticcholangiocarcinomasubtypesforimprovedpatientstratificationclinicalpathologicalandradiologicalconsiderations
AT dueberchristoph integrativeanalysisofintrahepaticcholangiocarcinomasubtypesforimprovedpatientstratificationclinicalpathologicalandradiologicalconsiderations
AT langhauke integrativeanalysisofintrahepaticcholangiocarcinomasubtypesforimprovedpatientstratificationclinicalpathologicalandradiologicalconsiderations
AT rothwilfried integrativeanalysisofintrahepaticcholangiocarcinomasubtypesforimprovedpatientstratificationclinicalpathologicalandradiologicalconsiderations
AT kloecknerroman integrativeanalysisofintrahepaticcholangiocarcinomasubtypesforimprovedpatientstratificationclinicalpathologicalandradiologicalconsiderations
AT straubbeatek integrativeanalysisofintrahepaticcholangiocarcinomasubtypesforimprovedpatientstratificationclinicalpathologicalandradiologicalconsiderations